Active Monitoring for Low-Risk Ductal Carcinoma In Situ—Reply

In Reply The Letter from Dr Lin and colleagues raises important points regarding the recent publication of the COMET trial for low-risk DCIS that merit further consideration.

Jun 10, 2025 - 17:15
 0
In Reply The Letter from Dr Lin and colleagues raises important points regarding the recent publication of the COMET trial for low-risk DCIS that merit further consideration.